Testing a new medication's safety in people with sickle cell disease

This early-stage trial is testing a medication called fostamatinib to see if it is safe and how well it is tolerated in people with sickle cell disease. Researchers want to understand whether this medication might help reduce inflammation and the sickling of red blood cells, which cause the painful symptoms and complications of sickle cell disease. The study will also measure how the medication affects certain blood markers and cell function.

Sickle cell disease causes severe pain, organ damage, and shortened lifespan due to abnormal red blood cells. Current treatments are limited, so researchers are exploring new medications that might reduce inflammation and prevent red blood cells from sickling.